Background: Technological innovations and accumulating experience have made it possible to use laparoscopic liver resection cases with re-existing adhesions or cicatricial changes. This study aimed to clarify the outcomes of laparoscopic repeat liver resection (LRLR) among cases of recurrent liver cancer after open liver resection. Methods: There were 157 patients who underwent laparoscopic liver resection for liver tumors at our institution during September 2012-September 2016. Sixty-two patients were included in analysis and were retrospectively divided into an LRLR group (n = 13) and a laparoscopic primary liver resection group (LPLR; n = 49), and the groups were compared in term of patient demographics, surgical procedures, and short-term surgical outcomes. Recurrence-free survival and overall survival were compared for patients with hepatocellular carcinoma and with colorectal liver metastases. Results: There was a significant inter-group difference in the hepatitis virus background (p= 0.036), but other patient demographics were comparable between the two groups. The two groups had similar values for extent of resection, operative time, estimated blood loss, transfusion requirement, conversion to laparotomy, postoperative complications, surgical margins, time to oral intake, and hospital stay. Furthermore, there were no inter-group differences in recurrence-free or overall survival in the LRLR and LPLR groups when we compared patients with hepatocellular carcinoma and patients with colorectal liver metastases. Conclusion: The LRLR and LPLR groups had equivalent short-term outcomes. Furthermore, LRLR does not compromise oncological outcomes compared to LPLR.
EP01C-056 SURGICAL OUTCOMES FOR NEUROENDOCRINE LIVER METASTASES: A RETROSPECTIVE, MULTICENTER SURVEY IN JAPAN
T. Aoki 1,2 , N. Kokudo 2 , J. Arita 2 , T. Masui 2 , A. Kudo 2 , I. Komoto 2 , T. Ito 2 , R. Y. Osamura 2 , M. Unno 2 and S. Uemoto 2 1 Second Department of Surgery, Dokkyo Medical University, and 2 The Japan Neuroendocrine Tumor Society (JNETS), Japan Background and aim: Surgical resection has been the treatment of choice for neuroendocrine liver metastases (NELM). However, high recurrence rate has been reported from the Western centers, and cure has been rarely achieved. In Asian countries, the tumor biology and patient demographics are widely different from those in the Western series, and little has not documented in terms of the surgical outcomes for NELM. Methods: This was a retrospective, multicenter, cohort study. The clinical data of initial hepatic resections for NELM were retrospectively collected. The variables examined included patient characteristics, tumor factors, operative outcomes, and postoperative recurrence and survival. Results: Thirty affiliations registered 222 cases. The primary tumor site was pancreas in 130 cases (59%), rectum in 28, duodenum in 19, and ileum in 10. The NELM was synchronous in 140 cases (63%) and metachronous in 82, and hepatic resection was performed concomitant with the resection of the primary tumor in 94 cases (42.3%). The hepatectomy procedure was limited resection in 115 cases (51.8%), lobectomy in 51 (23.0%) and segmentectomy in 33 (14.9%). Major complications occurred in 28 cases (13%) including 2 operative deaths. R0 resection was achieved in 63.1%, but tumor recurrence was found in 83.4% after R0/1 resections. The median recurrence-free and overall survival period was 14 and 113 months, respectively. Conclusions: This survey confirmed acceptable safety of concomitant resection of the primary site and NELM. Recurrence was frequent after hepatic resections, as reported from the Western series, and therefore, effective adjuvant treatment strategies are urgently needed. Introduction: A novel strategy for hepatectomy is required since advances in image simulation systems, such as CT volumetry, have allowed quantitative assessment of liver volume. We present a prediction scoring system for posthepatectomy liver failure (PHLF). Methods: A total of 232 patients who underwent hepatectomy between 2013 and 2016 were enrolled. We retrospectively analyzed each characteristic data multiplied with resection or remnant liver rate as risk factors for severe, grade-B or -C, PHLF. We constructed a new PHLF prediction score from 154 cases by 2015, and investigated its utility using validation cohort of 78 patients in 2016. Results: Severe PHLF occurred in 21/154 patients (13.6%). The results of univariate and multivariate analyses identified three independent risk factors: ICGR-15 (%) Â resection rate ! 3.11, Platelet (Â10 3 /ml) Â remnant rate 130.3, and PT (%) Â remnant rate 70.62 (P< 0.05). We decided cut-off values for each factor (3.0, 130, and 70.0, respectively) and constructed Volume-associated ICG-Platelet-PT score (VIPP score: 0-3), the sum of above HPB 2018, 20 (S2), S333eS504
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